Lancet Psychiatry / STAT News: No Evidence Cannabis Is Effective for PTSD, Anxiety, or Depression — A landmark systematic review and meta-analysis published in The Lancet Psychiatry in March 2026 analyzed 54 randomized controlled trials covering the period 1980–2025 and found no evidence that cannabinoids are effective for anxiety, PTSD, depression, bipolar disorder, ADHD, or […]
Study: Adolescent Cannabis Use Linked to Doubling Risk of Psychotic and Bipolar Disorders – A longitudinal cohort study of 463,396 adolescents ages 13–17, followed through age 26, found that past-year cannabis use during adolescence was associated with approximately twice the risk of developing psychotic or bipolar disorders. Study: Moderate Cannabis Use May Protect the Aging
January 2026 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. If you would
Today, President Trump signed an Executive Order (EO), Increasing Medical Marijuana and Cannabidiol Research. While the EO is being widely hailed as a significant advancement in marijuana legalization, in fact, the EO is extremely limited as to marijuana and has no independent legal effect at all on rescheduling marijuana. The EO does represent a potentially
Study: Cannabis use is not uniformly harmful to cognition in older adults. Past use was associated with better performance and slower decline in certain cognitive domains. However, specific usage patterns, such as longer duration, were associated with poorer outcomes in other domains. The theory that marijuana use can negatively—and potentially permanently—rewire the brain up until
Study: Inhaling Cannabis May Greatly Increase Your Risk of Lung Disease. The study found that inhaling marijuana every day is associated with a 44% increased chance of developing asthma. It also increases the odds of developing a common set of lung diseases known as chronic obstructive pulmonary disease (COPD) by 27%. Study: An experimental medication
Research reveals vaping cannabinoid mixtures produces a chemical that destroys human tissue. Study: Using cannabis and psilocybin together may increase dependence. Study: cannabis users display brain network characteristics typically associated with younger brains, along with enhanced cognitive abilities, highlighting a potential modulatory role for cannabinoids and endocannabinoids in neurodegenerative processes, as explained through neural dedifferentiation
A study published in JAMA Neurology suggests that individuals who receive acute care for cannabis use may be at an increased risk for incident dementia compared to the general population. A new federally funded study determined that starting treatment with THC-dominant medicinal cannabis was linked to immediate reductions in anxiety and depression. A study on
Compared with the general population or individuals who receive all-cause hospital-based care, those with acute care due to cannabis use may be at an increased risk for incident dementia, according to study results published in JAMA Neurology. Psychedelic substances, particularly when combined with behavioral therapies such as Motivational Enhancement Therapy (MET), show significant promise in
In a journal publication in Gastrointestinal Endoscopy, University of Oklahoma College of Medicine physician-researchers found that, during an endoscopy, cannabis users were 77% more likely to require higher doses of the anesthetic propofol compared to non-users, and 57% more likely to need higher doses of the sedative midazolam. In addition, diphenhydramine, an antihistamine often used for extra sedation, was
The robust science-based framework established by Congress for regulating food and color additives is encountering significant challenges. Concerns about these additives, first raised by advocacy groups, have been picked up by state legislatures. These concerns have been further amplified by the Make America Healthy Again (MAHA) movement and U.S. Health and Human Services (HHS) Secretary
March 2025 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. If you would
Researchers at the George Washington University say a condition called cannabinoid hyperemesis syndrome occurs in people who are long-term regular consumers of cannabis and causes nausea, uncontrollable vomiting and excruciating pain in a cyclical pattern that often leads to repeated trips to the hospital. The use of medical cannabis products by qualified patients ages 50
January 2025 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. If
December 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. Please contact us if you have any questions or want more information about any of the items below. We also track cannabis-related legislation introduced in the U.S. Congress. If you
November 2024 OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about any of the items below, please contact us. We also track cannabis-related legislation introduced in the U.S. Congress. If you would
The U.S. Supreme Court heard oral arguments in the case of a trucker who sued a cannabis company after he was fired over a positive THC test that he says was caused by consuming a hemp-derived CBD product. Report: The U.S. cannabis industry will need between $65.6B and $130.7B in sustainable growth capital to support new cannabis
Weed Companies Are Making More Money Selling Beer Than Cannabis (Bloomberg) Barstool Sports announced its new partnership with multi-state cannabis operator Green Thumb Industries (GTI). Athletes, investors eye Fusion CBD Products as popularity of buying CBD online increases Schedule III Classification Offers New Opportunities For The Pre-Roll Industry 4 Reasons Why Cannabis Stocks Are a
Home Depot, one of the largest employers in the United States, is shifting its employee drug testing policies to remove cannabis from screening panels entirely and stop pre-employment drug testing of most of its workers. Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., today announces a partnership with the Carvana PPA
WEEK OF JUNE 21, 2024 CannaSweep will be on hiatus given the Congressional recess and federal holiday. We will resume in August. OFW’s Cannabis Team regularly monitors cannabis news, legislation, regulation, and policy so our clients stay up-to-date on the latest developments impacting their business. If you have any questions or would like more information about
Marijuana brand Stiiizy has triggered a public health crisis among teens by “marketing dangerous, high potency marijuana vaporizers” to youth, according to a lawsuit filed by an unidentified California high school student. Biden’s DEA Marijuana Scam: MMJ BioPharma Awaits Marijuana Registration to Grow Pharmaceutical Cannabis Curaleaf Holdings, Inc., a leading international provider of consumer products
How a Farm Bill amendment could ‘significantly impact’ hemp brands. Two West Coast police groups have changed their positions and now support federal cannabis legalization efforts, marking the first time that a statewide police officers organization has called for an end to the nation’s prohibition of marijuana. Cannabis producer Green Thumb Industries has expressed interest
Organic Payment Gateways, a leading provider of alternative payment processing integrations, is excited to announce the launch of its new Authorize.Net payment gateway solutions tailored specifically for businesses in the CBD, nutritional supplement, and Farm Bill-compliant cannabis seed industries. Cannabis reclassification opens up new opportunities for software developers interested in tapping into this lucrative, but challenging, market. Reclassification of
Can the boom in weed drinks last? (Morning Brew) Leafly Holdings, Inc. Reports First Quarter 2024 Financial Results – Reported net loss of $2.4 million and adjusted EBITDA1 loss of $0.9 million Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective Top Marijuana
On May 16, President Biden made official what was previously announced on May 3 – the Drug Enforcement Administration (DEA), through the Department of Justice (DOJ), is proposing via rulemaking, to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). We’ve been expecting the proposed rule for two weeks; a
DEA Proposes To Reschedule Marijuana Read More »
Top public cannabis companies lost more than $2B in 2023 despite nearly $9B in revenue. Twenty of the largest publicly traded marijuana companies in the U.S. lost a cumulative $2.3 billion last year, and only one of them turned a profit. Adult-Use Cannabis Legalization States Surpass $20 Billion in Tax Revenue Cashing In on Cannabis:
On May 1, 2024, Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR), and Senator Cory Booker (D-N.J.) reintroduced the Cannabis Administration Opportunity Act (text available here). The reintroduction follows the news last week that the Drug Enforcement Administration (DEA) had begun the formal rulemaking process to move marijuana from Schedule I
Approved Human and Animal Drugs. FDA oversees and pre-approves the approval of pharmaceutical drugs derived from cannabis. Marijuana itself is not an FDA-approved drug. FDA has approved one cannabis-derived drug product, Epidiolex (CBD), and three synthetic cannabis-related drug products, Marinol (dronabinol), Syndros (dronabinol), and Cesamet (nabilone). FDA has not approved a marketing application for any other
DEA Moving To Reschedule Marijuana?! Read More »
Report: Cannabis Industry Employs More Than 440,000 Full-time Workers. Cannabis Rolling Papers May Pose Health Risks From Heavy Metals, Study Finds (Forbes). Innocan Pharma Corporation announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the FDA, for its Liposome-Cannabidiol (LPT-CBD) injectable treatment of chronic pain. With the move,
Q&A: U.S. Hemp Authority President Chris Fontes – The industry group is creating a certification program for intoxicating hemp products, reflecting heightened concerns about the burgeoning market. (Politico) Organic Payment Gateways Announces a “Square Payment Processing Alternatives for CBD” Support Program – Reacting to increased interest from both retail and e-commerce CBD and hemp businesses, OrganicPaymentGateways.com has
Publicly traded marijuana multistate operators exited regulated cannabis markets through late 2023, continuing a pattern fueled by increased capital costs, high taxes, and the slow pace of federal reform (This map pinpoints where the large MSOs are operating.) York views Flora Match, an AI-powered platform, as a game-changer in how cannabis products are selected and purchased,
The Big Problem for Marijuana Companies? What to Do With All That Cash. Few banks will work with cannabis upstarts—but some lawmakers hope to change that this year (The Wall Street Journal) OSHA Enforcement and Guidance on Protecting Workers within the Cannabis Industry – Webinar Series Medical Marijuana: New Court Ruling on Impairment at Work
Handheld Marijuana Vaporizer Market Size to Hit USD 15.9 billion by 2031, Projected a 13.4% CAGR – Report by Transparency Market Research, Inc. Worker Advances Medical Cannabis Claim, Wrongful Discharge Nixed – A worker who lost her job at a scaffolding company after a positive drug test can move forward with allegations under a state
Biden also tweeted during the SOTU, “No one should be jailed just for using or possessing marijuana.” Does Biden overpromise, underdeliver on marijuana reform? VP Harris to meet with marijuana pardon recipients at White House this week as Biden leans into issue ahead of election. USDA: USDA released its “Hemp Research Needs Roadmap,” which reflects
Options for buying a cannabis business in a dry capital market. Other Noteworthy Updates It’s 2024 And federal Law Still Does Not Protect Medical Marijuana Users From Getting Fired For Testing Positive (Mondaq). Cannabis Tax Frenzy (Forbes). Medical marijuana companies have stronger 280E argument: Former U.S. Justice Department’s Tax Division Official’s Opinion. Navigating Hemp
